UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

Leukemia, 2011-07, Vol.25 (7), p.1200-1202

2011

Volltextzugriff (PDF)

Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia

Leukemia, 2015-03, Vol.29 (3), p.526-534

2015

Volltextzugriff (PDF)

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

Blood cancer journal (New York), 2016-09, Vol.6 (9), p.e473-e473

2016

Volltextzugriff (PDF)

A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis

Leukemia, 2017-02, Vol.31 (2), p.393-402

2017

Volltextzugriff (PDF)

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

Leukemia, 2010-07, Vol.24 (7), p.1302-1309

2010

Volltextzugriff (PDF)

Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

Leukemia, 2018-04, Vol.32 (4), p.1034-1037

2018

Volltextzugriff (PDF)

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

Science translational medicine, 2018-04, Vol.10 (436)

2018

Volltextzugriff (PDF)

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

Haematologica (Roma), 2016-12, Vol.101 (12), p.1524-1533

2016

Volltextzugriff (PDF)

19 AN OBJECTIVE GENETIC ONTOGENY CLASSIFICATION IDENTIFIES TRUE BIOLOGICAL SECONDARY AML AMONG DE NOVO AML PATIENTS ≥60 YEARS OLD

Leukemia research, 2015-04, Vol.39, p.S8-S8

2015

Volltextzugriff (PDF)

Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy

Journal of oncology pharmacy practice, 2012-12, Vol.18 (4), p.436-439

2012

Volltextzugriff (PDF)

Tracing sources of atmospheric sulphur using epiphytic lichens

Environmental pollution (1987), 1999-01, Vol.106 (3), p.265-271

1999

Volltextzugriff (PDF)

KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32)

Leukemia, 2005, Vol.19 (1), p.27-30

2005

Volltextzugriff (PDF)

Lichen response to changes in atmospheric sulphur: isotopic evidence

Environmental pollution (1987), 2002, Vol.116 (2), p.235-241

2002

Volltextzugriff (PDF)

Tracing sources of precipitation sulfate in eastern Canada using stable isotopes and trace metals

Journal of Geophysical Research, Washington, DC, 2000-08, Vol.105 (D16), p.20549-20556

2000

Volltextzugriff (PDF)

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance

British journal of haematology, 2005-10, Vol.131 (2), p.208-213

2005

Volltextzugriff (PDF)

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

Blood, 2003-09, Vol.102 (5), p.1578-1582

2003

Volltextzugriff (PDF)

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

British journal of haematology, 2005-11, Vol.131 (3), p.320-328

2005

Volltextzugriff (PDF)

PKC412 Inhibits the Zinc Finger 198-Fibroblast Growth Factor Receptor 1 Fusion Tyrosine Kinase and Is Active in Treatment of Stem Cell Myeloproliferative Disorder

Proceedings of the National Academy of Sciences - PNAS, 2004-10, Vol.101 (40), p.14479-14484

2004

Volltextzugriff (PDF)

Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment

Current opinion in hematology, 2003-11, Vol.10 (6), p.451-462

2003

Volltextzugriff (PDF)

Isotopic evidence for the origin of sulphate in coastal rain

Tellus. Series B, Chemical and physical meteorology, 1996-02, Vol.48 (1), p.44-59

1996

Volltextzugriff (PDF)

Sulphur isotope tests of seasalt correction factors in precipitation : Nova Scotia, Canada

Water, air, and soil pollution, 1994-09, Vol.77 (1-2), p.1-16

1994

Volltextzugriff (PDF)

Identification and Characterization of Saccharomyces cerevisiae Dihydrosphingosine-1-phosphate Phosphatase

The Journal of biological chemistry, 1997-11, Vol.272 (45), p.28690-28694

1997

Volltextzugriff (PDF)

S828 A RANDOMIZED, DOUBLE BLIND PHASE 2 STUDY OF 3 DIFFERENT DOSES OF PRM‐151 IN PATIENTS WITH MYELOFIBROSIS WHO WERE PREVIOUSLY TREATED WITH OR INELIGIBLE FOR RUXOLITINIB

HemaSphere, 2019-06, Vol.3 (S1), p.367-n/a

2019

Volltextzugriff (PDF)

1 – 25 von 335

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(295)

Publikationsform

Sprache

Englisch
(335)

Erscheinungsjahr

n.n

Thema

Science & Technology
(183)
Life Sciences & Biomedicine
(165)
Humans
(160)
Male
(87)
Female
(79)
Biological And Medical Sciences
(78)
Medical Sciences
(68)
Oncology
(55)
Middle Aged
(54)
Hematology
(50)
Aged
(46)
Adult
(45)
Bipolar Disorder - Genetics
(42)
Psychiatry
(33)
Psychology. Psychoanalysis. Psychiatry
(32)
Psychopathology. Psychiatry
(32)
Adult And Adolescent Clinical Studies
(31)
Bipolar Disorder
(28)
Genetics & Heredity
(25)
Mood Disorders
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

19 AN OBJECTIVE GENETIC ONTOGENY CLASSIFICATION IDENTIFIES TRUE BIOLOGICAL SECONDARY AML AMONG DE NOVO AML PATIENTS ≥60 YEARS OLD

Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy

Tracing sources of atmospheric sulphur using epiphytic lichens

KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32)

Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Lichen response to changes in atmospheric sulphur: isotopic evidence

Tracing sources of precipitation sulfate in eastern Canada using stable isotopes and trace metals

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

PKC412 Inhibits the Zinc Finger 198-Fibroblast Growth Factor Receptor 1 Fusion Tyrosine Kinase and Is Active in Treatment of Stem Cell Myeloproliferative Disorder

Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment

Isotopic evidence for the origin of sulphate in coastal rain

Sulphur isotope tests of seasalt correction factors in precipitation : Nova Scotia, Canada

Identification and Characterization of Saccharomyces cerevisiae Dihydrosphingosine-1-phosphate Phosphatase

S828 A RANDOMIZED, DOUBLE BLIND PHASE 2 STUDY OF 3 DIFFERENT DOSES OF PRM‐151 IN PATIENTS WITH MYELOFIBROSIS WHO WERE PREVIOUSLY TREATED WITH OR INELIGIBLE FOR RUXOLITINIB

Suchergebnisse filtern